News | Latest Breaking News Stories & Headlines | RTÉ

skip to main content

Eli Lilly forecasts 2025 profit growth

Eli Lilly has today forecast annual profit largely above Wall Street estimates, providing some relief to investors after another quarter of sales miss for its popular diabetes and weight-loss treatments.
Business • 06 Feb

Eli Lilly ups 2024 sales view on weight-loss drug demand

Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2 billion today, lifting its shares nearly 6%.
Business • 30 Apr 24

Eli Lilly expects strong 2024 profits

Eli Lilly has today forecast 2024 profit above Wall Street estimates on soaring demand for its weight-loss drug, and said the treatment helped reduce symptoms of a fatty liver disease in a mid-stage trial.
Business • 06 Feb 24

Search RTÉ.ie

Cant find what you're looking for?